Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 6
2016 3
2017 5
2018 3
2019 7
2020 11
2021 11
2022 13
2023 6
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19.
Soares MN, Eggelbusch M, Naddaf E, Gerrits KHL, van der Schaaf M, van den Borst B, Wiersinga WJ, van Vugt M, Weijs PJM, Murray AJ, Wüst RCI. Soares MN, et al. Among authors: naddaf e. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):11-22. doi: 10.1002/jcsm.12896. Epub 2022 Jan 7. J Cachexia Sarcopenia Muscle. 2022. PMID: 34997689 Free PMC article. Review.
Nelarabine-Induced Myelotoxicity.
Madhavan AA, Carr CM, Alkhateeb H, Staff NP, Naddaf E. Madhavan AA, et al. Among authors: naddaf e. Neurology. 2021 Jan 26;96(4):175-176. doi: 10.1212/WNL.0000000000011343. Epub 2020 Dec 11. Neurology. 2021. PMID: 33310877 No abstract available.
Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP. Dubey D, et al. Among authors: naddaf e. JAMA Neurol. 2019 Mar 1;76(3):301-309. doi: 10.1001/jamaneurol.2018.4053. JAMA Neurol. 2019. PMID: 30575890 Free PMC article.
Vasculitic Neuropathies.
Naddaf E, Dyck PJ. Naddaf E, et al. Curr Treat Options Neurol. 2015 Oct;17(10):374. doi: 10.1007/s11940-015-0374-1. Curr Treat Options Neurol. 2015. PMID: 26346349
Clinical spectrum of high-titre GAD65 antibodies.
Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, Gadoth A, Naddaf E, McKeon A, Pittock SJ, Zalewski NL. Budhram A, et al. Among authors: naddaf e. J Neurol Neurosurg Psychiatry. 2021 Feb 9;92(6):645-54. doi: 10.1136/jnnp-2020-325275. Online ahead of print. J Neurol Neurosurg Psychiatry. 2021. PMID: 33563803 Free PMC article.
Current status of clinical outcome measures in inclusion body myositis: a systematised review.
Roy B, Lucchini M, Lilleker JB, Goyal NA, Naddaf E, Adler B, Alfano LN, Malandraki GA, Focht Garand KL, Mochel D, Badrising U, Machado PM, Pagkatipunan R, Ramdharry G, Wang L, Funaro MC, Schmidt J, Kushlaf H, Schiopu E, Stipancic K, Goyal N, d'Alessandro M, Conticini E, Cruz-Coble B, Lloyd TE; International Myositis Assessment and Clinical Studies (IMACS) Inclusion Body Myositis Scientific Interest Group. Roy B, et al. Among authors: naddaf e. Clin Exp Rheumatol. 2023 Mar;41(2):370-378. doi: 10.55563/clinexprheumatol/ifacv3. Epub 2023 Feb 3. Clin Exp Rheumatol. 2023. PMID: 36762744 Free article. Review.
66 results